147 related articles for article (PubMed ID: 31256359)
1. Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis.
Morvan L; Carlier T; Jamet B; Bailly C; Bodet-Milin C; Moreau P; Kraeber-Bodéré F; Mateus D
Int J Comput Assist Radiol Surg; 2020 Jan; 15(1):129-139. PubMed ID: 31256359
[TBL] [Abstract][Full Text] [Related]
2. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials.
Jamet B; Morvan L; Nanni C; Michaud AV; Bailly C; Chauvie S; Moreau P; Touzeau C; Zamagni E; Bodet-Milin C; Kraeber-Bodéré F; Mateus D; Carlier T
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1005-1015. PubMed ID: 33006656
[TBL] [Abstract][Full Text] [Related]
3.
Zhong H; Huang D; Wu J; Chen X; Chen Y; Huang C
BMC Med Imaging; 2023 Jun; 23(1):87. PubMed ID: 37370013
[TBL] [Abstract][Full Text] [Related]
4. Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.
Bailly C; Carlier T; Jamet B; Eugene T; Touzeau C; Attal M; Hulin C; Facon T; Leleu X; Perrot A; Garderet L; Macro M; Caillot D; Moreau P; Kraeber-Bodéré F; Bodet-Milin C
Clin Cancer Res; 2018 Nov; 24(21):5219-5224. PubMed ID: 30068709
[No Abstract] [Full Text] [Related]
5. The Relative Importance of Clinical and Socio-demographic Variables in Prognostic Prediction in Non-Small Cell Lung Cancer: A Variable Importance Approach.
He J; Zhang JX; Chen CT; Ma Y; De Guzman R; Meng J; Pu Y
Med Care; 2020 May; 58(5):461-467. PubMed ID: 31985586
[TBL] [Abstract][Full Text] [Related]
6. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Magnetic Resonance Imaging and [
Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment
Ahn HK; Lee H; Kim SG; Hyun SH
Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
[TBL] [Abstract][Full Text] [Related]
12. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
Dimitrakopoulou-Strauss A; Hoffmann M; Bergner R; Uppenkamp M; Haberkorn U; Strauss LG
Clin Nucl Med; 2009 Sep; 34(9):576-84. PubMed ID: 19692817
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Baseline
Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Chemotherapy Response of Osteosarcoma Using Baseline
Jeong SY; Kim W; Byun BH; Kong CB; Song WS; Lim I; Lim SM; Woo SK
Contrast Media Mol Imaging; 2019; 2019():3515080. PubMed ID: 31427908
[TBL] [Abstract][Full Text] [Related]
16. Radiomic Profiling of Head and Neck Cancer:
Feliciani G; Fioroni F; Grassi E; Bertolini M; Rosca A; Timon G; Galaverni M; Iotti C; Versari A; Iori M; Ciammella P
Contrast Media Mol Imaging; 2018; 2018():3574310. PubMed ID: 30363632
[TBL] [Abstract][Full Text] [Related]
17. PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.
Zamagni E; Nanni C; Mancuso K; Tacchetti P; Pezzi A; Pantani L; Zannetti B; Rambaldi I; Brioli A; Rocchi S; Terragna C; Martello M; Marzocchi G; Borsi E; Rizzello I; Fanti S; Cavo M
Clin Cancer Res; 2015 Oct; 21(19):4384-90. PubMed ID: 26078390
[TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.
van Lammeren-Venema D; Regelink JC; Riphagen II; Zweegman S; Hoekstra OS; Zijlstra JM
Cancer; 2012 Apr; 118(8):1971-81. PubMed ID: 21887677
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma.
Saadani H; van der Hiel B; Aalbersberg EA; Zavrakidis I; Haanen JBAG; Hoekstra OS; Boellaard R; Stokkel MPM
J Nucl Med; 2019 Nov; 60(11):1545-1552. PubMed ID: 31481581
[TBL] [Abstract][Full Text] [Related]
20. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L
J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
